197 related articles for article (PubMed ID: 2456368)
1. Anti-IgM-mediated B cell signaling. Molecular analysis of ligand binding requisites for human B cell clonal expansion and tolerance.
Rudich SM; Roux KH; Winchester RJ; Mongini PK
J Exp Med; 1988 Jul; 168(1):247-66. PubMed ID: 2456368
[TBL] [Abstract][Full Text] [Related]
2. A monovalent C mu 4-specific ligand enhances the activation of human B cells by membrane IgM cross-linking ligands.
Mongini PK; Blessinger CA; Chiorazzi N; Rajaram N; Rudich SM
Int Immunol; 1995 Feb; 7(2):317-30. PubMed ID: 7734425
[TBL] [Abstract][Full Text] [Related]
3. The influence of avidity on signaling murine B lymphocytes with monoclonal anti-IgM antibodies. Effects of B cell proliferation versus growth inhibition (tolerance) of an immature B cell lymphoma.
Udhayakumar V; Kumar L; Subbarao B
J Immunol; 1991 Jun; 146(12):4120-9. PubMed ID: 2040794
[TBL] [Abstract][Full Text] [Related]
4. Membrane IgD and membrane IgM differ in capacity to transduce inhibitory signals within the same human B cell clonal populations.
Mongini PK; Blessinger C; Posnett DN; Rudich SM
J Immunol; 1989 Sep; 143(5):1565-74. PubMed ID: 2788188
[TBL] [Abstract][Full Text] [Related]
5. Affinity requirements for induction of sequential phases of human B cell activation by membrane IgM-cross-linking ligands.
Mongini PK; Blessinger CA; Dalton JP
J Immunol; 1991 Mar; 146(6):1791-800. PubMed ID: 2005379
[TBL] [Abstract][Full Text] [Related]
6. Analysis of the domain specificity of various murine anti-human IgM monoclonal antibodies differing in human B lymphocyte signaling activity.
Rudich SM; Mihaesco E; Winchester R; Mongini PK
Mol Immunol; 1987 Aug; 24(8):809-20. PubMed ID: 2443845
[TBL] [Abstract][Full Text] [Related]
7. Human B cell activation. Effect of T cell cytokines on the physicochemical binding requirements for achieving cell cycle progression via the membrane IgM signaling pathway.
Mongini PK; Highet PF; Inman JK
J Immunol; 1995 Oct; 155(7):3385-400. PubMed ID: 7561033
[TBL] [Abstract][Full Text] [Related]
8. B cell activation. V. Differentiation signaling of B cell membrane depolarization, increased I-A expression, G0 to G1 transition, and thymidine uptake by anti-IgM and anti-IgD antibodies.
Cambier JC; Monroe JG
J Immunol; 1984 Aug; 133(2):576-81. PubMed ID: 6610706
[TBL] [Abstract][Full Text] [Related]
9. Human leukemic B cell activation: functional consequence of membrane IgM interaction with anti-IgM ligand is an alterable cell characteristic.
Mongini P; Blessinger C; Seremetis S; Winchester R; Rudich S
Blood; 1987 Oct; 70(4):1193-202. PubMed ID: 3498519
[TBL] [Abstract][Full Text] [Related]
10. Mechanisms of clonal abortion tolerogenesis. II. Clonal behaviour of immature B cells following exposure to anti-mu chain antibody.
Nossal GJ; Pike BL; Battye FL
Immunology; 1979 May; 37(1):203-15. PubMed ID: 112040
[TBL] [Abstract][Full Text] [Related]
11. Circulating monoclonal IgM proteins in B cell chronic lymphocytic leukemia: their identification, characterization and relationship to membrane IgM.
Qian GX; Fu SM; Solanki DL; Rai KR
J Immunol; 1984 Dec; 133(6):3396-400. PubMed ID: 6333459
[TBL] [Abstract][Full Text] [Related]
12. Surface immunoglobulins are involved in the interaction of protein A with human B cells and in the triggering of B cell proliferation induced by protein A-containing Staphylococcus aureus.
Romagnani S; Giudizi MG; Biagiotti R; Almerigogna F; Maggi E; Del Prete G; Ricci M
J Immunol; 1981 Oct; 127(4):1307-13. PubMed ID: 6974188
[TBL] [Abstract][Full Text] [Related]
13. Induction and suppression of polyclonal antibody responses by anti-Ig reagents and antigen-nonspecific helper factors: a comparison of the effects of anti-Fab, anti-IgM, and anti IgD on murine B cells.
Parker DC
Immunol Rev; 1980; 52():115-39. PubMed ID: 7021394
[No Abstract] [Full Text] [Related]
14. In vivo generation and function of B cells in the presence of a monoclonal anti-IgM antibody: implications for B cell tolerance.
Gause A; Yoshida N; Kappen C; Rajewsky K
Eur J Immunol; 1987 Jul; 17(7):981-90. PubMed ID: 3497044
[TBL] [Abstract][Full Text] [Related]
15. The synergistic effects of anti-IgM and monoclonal anti-Ia antibodies in induction of murine B lymphocyte activation.
Baluyut AR; Subbarao B
J Mol Cell Immunol; 1988; 4(1):45-57. PubMed ID: 3266924
[TBL] [Abstract][Full Text] [Related]
16. Membrane IgM-mediated signaling of human B cells. Effect of increased ligand binding site valency on the affinity and concentration requirements for inducing diverse stages of activation.
Mongini PK; Blessinger CA; Highet PF; Inman JK
J Immunol; 1992 Jun; 148(12):3892-901. PubMed ID: 1376344
[TBL] [Abstract][Full Text] [Related]
17. Differential effects of cyclosporin A on diverse B cell activation phenomena triggered by crosslinking of membrane IgM.
Mongini PK; Blessinger CA; Dalton JP; Seki T
Cell Immunol; 1992 Apr; 140(2):478-94. PubMed ID: 1371950
[TBL] [Abstract][Full Text] [Related]
18. The affinity threshold for human B cell activation via the antigen receptor complex is reduced upon co-ligation of the antigen receptor with CD21 (CR2).
Mongini PK; Vilensky MA; Highet PF; Inman JK
J Immunol; 1997 Oct; 159(8):3782-91. PubMed ID: 9378965
[TBL] [Abstract][Full Text] [Related]
19. Evidence for an upper affinity threshold for anti-IgM-induced apoptosis in a human B-cell lymphoma.
Mongini PK; Liu Q; Vilensky MA; Highet PF; Inman JK
Blood; 1998 Nov; 92(10):3756-71. PubMed ID: 9808570
[TBL] [Abstract][Full Text] [Related]
20. Activation of human B cells and inhibition of their terminal differentiation by monoclonal anti-mu antibodies.
Maruyama S; Kubagawa H; Cooper MD
J Immunol; 1985 Jul; 135(1):192-9. PubMed ID: 3923101
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
